Drug Approval | July 14, 2023
Granules India announces approval for Acetaminophen and Ibuprofen Tablets
This product will be launched through Granules Consumer Health (GCH) division
This product will be launched through Granules Consumer Health (GCH) division
PEEK brings a new quality to dental care for patients
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
Suven Life Sciences completed enrollment of patients to the phase-2, PoC clinical study of samelisant (SUVN-G3031) for the treatment of narcolepsy with or without cataplexy in USA and Canada
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Subscribe To Our Newsletter & Stay Updated
